Summit Therapeutics press releases
The latest press releases from Summit Therapeutics (NASDAQ: SMMT), gathered from its own newsroom and from the newswires that carry it. PPN World follows 1,400+ press release feeds and adds each Summit Therapeutics release within minutes of publication.
- Listing
- NASDAQ: SMMT
- Latest release
- Oct 24, 2026
- On this page
- 2 newest releases
Latest Summit Therapeutics press releases
- Lunit and Summit Therapeutics Announce Agreement to Apply AI-powered SCOPE IO Platform for Tumor Microenvironment Analysis in Immuno-Oncology Development
Research Will Use Lunit's AI-powered Pathology Platform to Analyze H&E Whole-Slide Images and Generate Scalable Insights into Tumor Microenvironment Biology SEOUL, South Korea, Oct. 24, 2026 /PRNewswi…
- Akeso Announces Summit Therapeutics and ECOG-ACRIN Cancer Research Group Enter into Phase II/III Clinical Trial Collaboration to Evaluate Ivonescimab in First-Line Biliary Tract Cancer
Becomes the 7th International Registrational Clinical Trial for Ivonescimab Clinical Trial Site Activations in the United States Expected to Begin Q4 2026 HONG KONG, Oct. 21, 2026 /PRNewswire/ -- Akes…
PPN World is independent and not affiliated with Summit Therapeutics. Headlines and short excerpts only; each release links to its source.
Questions
Where can I find Summit Therapeutics press releases?+
How do I get an alert when Summit Therapeutics publishes a press release?+
Is this Summit Therapeutics's official newsroom?+
Know the minute Summit Therapeutics publishes
Watch Summit Therapeutics, its competitors and its sector in one live feed, with email alerts — on the free plan.